Core Insights - HONOR is advancing its Augmented Human Intelligence (AHI) vision and accelerating its ALPHA PLAN through three interconnected pillars: Alpha Phone, Alpha Store, and Alpha Lab [1][3] - The company unveiled the Robot Phone, a new type of smartphone that integrates embodied intelligence, allowing for motion and spatial awareness [1][4] - HONOR's Magic V6 foldable device features advanced silicon-carbon battery technology and AI-enhanced productivity, reinforcing its commitment to intelligent hardware and software [2] Product Innovations - The Robot Phone combines embodied AI interaction with robot-grade motion and cinematic imaging capabilities, offering a more expressive and natural user experience [4][5] - It features a self-developed micro motor and a compact 4DoF gimbal system, enabling advanced motion control and stabilization [6][7] - The device is equipped with a 200MP sensor and a stabilized gimbal camera system, aimed at enhancing video capture quality and storytelling [8][9] Strategic Vision - CEO James Li emphasized a human-centric approach, integrating IQ and EQ to explore new paradigms in AI devices and ecosystems [3] - The ALPHA PLAN aims to create a comprehensive AI ecosystem that meets real human needs through intelligent hardware and software integration [2][3] - HONOR's focus on embodied intelligence positions the company at the forefront of the next generation of mobile technology [10]

Beijing, China--(Newsfile Corp. - March 2, 2026) - China News Service (CNS) issued a report Saturday in Beijing to promote the Chinese northern Province of Hebei. CNS praised the province’s recent gathering of global resources and its acceleration in the creation of a new high ground for foreign trade and investment.Cannot view this video? Visit:https://www.youtube.com/watch?v=ZZ0T_mBlQewLocated near the Bohai Sea and encircling Beijing and Tianjin, Hebei stands at the forefront of China's era of opening u ...

Core Viewpoint - PayPay, operated by SoftBank Group, is planning a U.S. initial public offering (IPO) which could significantly enhance SoftBank's financial resources as it invests heavily in artificial intelligence [1] Group 1 - The IPO of PayPay is expected to provide a substantial influx of capital for SoftBank Group [1] - SoftBank Group is currently investing billions into artificial intelligence, indicating a strategic focus on this sector [1]

Core Viewpoint - Verde AgriTech Ltd. is conducting a brokered private placement to raise up to $4,500,000 through the sale of units priced at $1.20 each, which will include shares and warrants [1][2]. Group 1: Offering Details - The offering consists of up to 3,750,000 units, each unit comprising one ordinary share and one share purchase warrant [1][2]. - Each warrant allows the holder to purchase an additional share at a price of $1.65 for a period of 30 months following the closing date [2]. - The offering will be conducted on a "best efforts" basis by A.G.P. Canada Investments ULC, which will act as the lead agent [1]. Group 2: Regulatory and Compliance - The units will be offered under the listed issuer financing exemption in certain Canadian provinces, and the securities will not be subject to a hold period under applicable Canadian securities laws [3]. - The offering may also be issued in the United States under exemptions from registration requirements [3][8]. Group 3: Financial Terms - The agent will receive a cash commission of 6.0% of the gross proceeds and will be issued non-transferable broker warrants representing 3.0% of the total units sold [4]. - The net proceeds from the offering will be used to accelerate work on the Minas Americas Global Alliance rare earth project, including resource definition drilling and technical de-risking [5]. Group 4: Timeline and Conditions - The offering is expected to close on or about March 12, 2026, subject to necessary approvals, including from the Toronto Stock Exchange [6]. - The company is relying on specific exemptions to distribute securities and is qualified under the relevant regulations [3].

Core Viewpoint - Verde AgriTech Ltd. is conducting a brokered private placement to raise up to $4,500,000 through the sale of units priced at $1.20 each, which will include ordinary shares and warrants [1][2]. Group 1: Offering Details - The offering consists of up to 3,750,000 units, each unit comprising one ordinary share and one share purchase warrant [1][2]. - Each warrant allows the holder to purchase an additional share at a price of $1.65 for a period of 30 months following the closing date [2]. - The offering will be conducted on a "best efforts" basis by A.G.P. Canada Investments ULC, which will act as the lead agent [1]. Group 2: Regulatory and Financial Aspects - The units will be offered under the listed issuer financing exemption, allowing for the securities to be issued without a hold period in certain Canadian provinces [3]. - The agent will receive a cash commission of 6.0% of the gross proceeds and will be issued non-transferable broker warrants representing 3.0% of the units sold [4]. - The net proceeds from the offering will be used to advance the Minas Americas Global Alliance rare earth project, including resource definition drilling and technical de-risking [5]. Group 3: Timeline and Conditions - The offering is expected to close on or about March 12, 2026, subject to necessary approvals, including from the Toronto Stock Exchange [6]. - The offering document will be available on the company's profile on SEDAR+ and its website for prospective investors [7]. Group 4: Company Overview - Verde AgriTech is a Brazil-focused specialty fertilizer company listed on the TSX and OTCQX, advancing its rare earth project in Minas Gerais [9].

Core Viewpoint - MAIA Biotechnology, Inc. has announced a public offering of 20 million shares at a price of $1.50 per share, aiming to raise $30 million for clinical trials and general corporate purposes [1][2]. Group 1: Offering Details - The public offering consists of 20,000,000 shares priced at $1.50 each, with expected gross proceeds of $30 million before expenses [1]. - The underwriters have a 45-day option to purchase an additional 3,000,000 shares at the same price to cover over-allotments [1]. - The offering is structured as a common stock-only investment with no warrant coverage [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for conducting clinical trials, working capital, and general corporate purposes [2]. Group 3: Regulatory Information - The securities are being offered under a "shelf" registration statement filed with the SEC, which became effective on August 23, 2023 [3]. - A prospectus supplement detailing the terms of the offering will be filed with the SEC [4]. Group 4: Company Overview - MAIA Biotechnology focuses on developing targeted immunotherapies for cancer, with its lead program being ateganosine (THIO), aimed at treating NSCLC patients with telomerase-positive cancer cells [7].

Core Viewpoint - Asian government bonds experienced a sell-off due to concerns that the ongoing conflict in the Middle East will lead to increased inflation and accelerated interest rate hikes [1] Group 1 - The sell-off in Asian government bonds occurred on Tuesday [1] - Fears surrounding the Middle East conflict are driving market reactions [1] - Investors are worried about the implications for inflation and interest rates [1]

Group 1 - Meren Energy (MRNFF) does not operate any of its joint ventures, which means it lacks control over its growth or decline [2] - The oil and gas industry is characterized as a boom-bust, cyclical sector, requiring patience and experience for successful investment [2] - The investing group Oil & Gas Value Research focuses on under-followed oil companies and midstream companies that present compelling investment opportunities [2] Group 2 - The article serves as an update on Meren Energy's latest earnings and progress, reflecting the ongoing analysis conducted by the investing group [2] - The group includes an active chat room for Oil & Gas investors to discuss recent information and share investment ideas [2]

Core Viewpoint - The article emphasizes the critical importance of resources such as gas and water for civilization, drawing a parallel to the role of central banks and monetary policy in maintaining economic stability [1]. Group 1 - The central bank's forward guidance and FOMC meetings are becoming less relevant in the current economic landscape [1]. - The author has over 10 years of experience in managing multi-asset strategies and equity portfolios, focusing on macroeconomic factors and stock selection [1]. - The analysis includes a focus on earnings, technological disruption, policy shifts, and capital flows to identify mispriced investment opportunities [1].

Market Overview - Indian share markets are closed on March 3 due to the Holi festival holiday, with trading suspended on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) [1] - The Multi Commodity Exchange of India (MCX) will resume trading in the evening session from 5 pm to 11 pm [2] Global Market Trends - Major Asian indices experienced selling pressure, with Japan's Nikkei 225 down by 1.71% to 57,065, Hong Kong's Hang Seng down by 0.24% to 25,985, Taiwan's Weighted Index down by 0.36% to 34,967, and South Korea's KOSPI down by 2.42% [2] - Conversely, Singapore's Straits Times index gained 0.94% [2] Crude Oil Prices - Crude oil prices surged amid geopolitical tensions, with Brent crude increasing by approximately 1% to USD 78.52 per barrel [3] Domestic Market Performance - On March 2, domestic equity benchmarks faced a significant sell-off due to escalating military tensions between the US, Israel, and Iran, leading to a global "risk-off" sentiment [4] - The Sensex closed at 80,238.85 points, down 1,048.34 points or 1.29%, while the Nifty ended at 24,865.70 points, down 312.95 points or 1.24% [4] - Market participants are expected to track global cues and crude oil price movements when trading resumes after the holiday [4]